| CPT Code | Device Type / Description | Professional / Technical Split | Frequency Limit & Common Billing Pairs |
|---|---|---|---|
| 93294 | Remote interrogation, pacemaker system (single, dual, or multiple lead) | CPT 93294 is the professional component (PC) for remote pacemaker interrogation evaluation (up to 90 days), and the corresponding technical component is billed separately as 93296 | Up to once per 90-day period, pairs with 93296 when applicable |
| 93295 | Remote interrogation, ICD system (single, dual, or multiple lead) | Professional component (modifier 26) | Once per 90-day period, billed with 93296 for technical component |
| 93296 | Remote data transmission, ICD or pacemaker (technical component) | Technical component (modifier TC) | Once per 90-day period, paired with 93295 or 93294 as applicable |
| 93297 | Remote interrogation, implantable cardiovascular physiologic monitor (ICPM / CardioMEMS) | Professional component (modifier 26) | Once per 30-day period, may pair with 93298 when ICM data is also reviewed |
| 93298 | Remote interrogation, implantable cardiac monitor (ICM) / loop recorder | CPT 93298 is the base code that may be reported with modifier 26 for the professional component or TC for the technical component | Monitoring periods described as up to 30 days per code descriptor |
| 93285 | In-person programming evaluation of an already implanted ICM/subcutaneous cardiac rhythm monitor system | CPT 93285 may be billed with the professional component modifier 26 | Typically reported at time of implant |
| 0650T | Remote programming device evaluation (with iterative adjustment, analysis, review and report) of a subcutaneous cardiac rhythm monitor system | Global (Category III, no established split) | Per session, payer coverage varies, requires synchronous physician oversight documentation |
| G2066 | Remote monitoring of cardiac implantable device (deleted effective January 1, 2024) | G2066 was the technical component (carrier-priced) for remote interrogation device evaluation under CPT 93297/93298 | Subject to frequency limits until deleted effective January 1, 2024 |
AMA CPT resources provide the authoritative descriptor language for each code above. Frequency limits for codes 93293–93298 follow CMS remote monitoring policy and related Medicare LCD guidance.
CPT 93298 describes remote interrogation of an ICM or ILR over a monitoring period of up to 30 days. CMS guidance addresses remote monitoring codes 93293–93296 and related codes for implantable cardiac monitors, and payers often mirror these rules.
Bill 93298 only when a completed remote transmission is received from the ICM or ILR, a physician or qualified NPP reviews the transmitted data, and a signed interpretation report exists within the billing period. The billing period resets from the date of the last billable interrogation, not from a calendar quarter boundary. Practices that rely on manual portal checks can miss minimum thresholds or submit claims outside the allowed window, which generates denials that are difficult to appeal retroactively. To avoid these errors, teams need clear device-type rules and automated tracking of each eligible monitoring period.
| Attribute | CPT 93297 | CPT 93298 |
|---|---|---|
| Device type | Implantable cardiovascular physiologic monitor (ICPM), for example CardioMEMS PA sensor | Implantable cardiac monitor (ICM) or implantable loop recorder (ILR) |
| Data reviewed | Hemodynamic data such as pulmonary artery pressure and fluid status | Cardiac rhythm data such as arrhythmia detection and R-R intervals |
| Billing frequency | Once per 30-day period | Monitoring periods described as up to 30 days per code descriptor |
| Reimbursement notes | Professional component billed with modifier 26, reflects continuous hemodynamic surveillance needs | Professional component billed with modifier 26, aligns with ILR transmission schedules per descriptor |
The most common denial error involves billing 93298 for a CardioMEMS device or 93297 for an ILR. Device-type verification at the point of data ingestion, not at claim submission, provides the most reliable prevention strategy.
CPT 93295 and 93296 are designed to be reported together when a single practice owns both the clinical interpretation and the data transmission infrastructure. When a hospital or independent monitoring service owns the transmission equipment, 93296 is billed by that entity with modifier TC, and the interpreting physician bills 93295 with modifier 26.
Common denial reasons for this pair include billing both codes under the same NPI when the technical component belongs to a separate entity, submitting 93296 without a corresponding 93295 or 93294 on the same claim, and billing outside payer frequency guidelines. Medicare LCD guidance outlines reporting rules for 93295 and 93296, and similar logic applies to 93297 and 93298.
0650T is a Category III CPT code for remote programming device evaluation (with iterative adjustment, analysis, review and report) of a subcutaneous cardiac rhythm monitor system. Category III codes are temporary AMA codes used to collect data on emerging technologies, and they do not carry a national Medicare Physician Fee Schedule RVU assignment by default. Reimbursement depends entirely on individual payer policy.
Required documentation for 0650T includes the clinical indication for remote reprogramming rather than in-person reprogramming, confirmation of synchronous real-time physician oversight during the reprogramming session, the specific parameter changes made, the device manufacturer and model, and post-reprogramming device interrogation confirming successful parameter application. As of mid-2026, Medicare does not have a finalized national coverage determination for 0650T, so coverage is adjudicated at the MAC level. Several commercial payers classify 0650T as investigational. Practices should verify payer-specific coverage before performing remote reprogramming and document medical necessity thoroughly to support any appeal.
Traditional Medicare takes a streamlined approach to authorization for remote cardiac implant monitoring codes, but the specific billing rules still matter for claim success. For cardiac implant monitoring, Medicare applies the 90-day frequency limits described earlier and does not require a separate ordering provider NPI on the claim.
Commercial payer policies diverge significantly. Aetna updated its remote physiologic monitoring policy in February 2026 to limit RPM coverage to heart failure, hypertension, and diabetes only, and covers only CPT codes 99453, 99454, 99457, and 99458, while the newer 2026 codes 99445 and 99470 are listed as not covered. Cigna's commercial RPM policy requires that monitoring be integrated into a documented 30-day treatment plan, and standalone monitoring without evidence of clinical response is frequently denied. UnitedHealthcare delayed its planned 2026 restrictions, which would have limited coverage to chronic heart failure and hypertensive disorders of pregnancy, until further notice, so current coverage remains aligned with CMS definitions. Anthem's Medicare Advantage plans fully align with Traditional Medicare and the 2026 CMS Physician Fee Schedule. Prior authorization requirements for cardiac implant monitoring codes vary by payer and plan, so practices should verify requirements at the time of device implant, not at the time of the first transmission.
Every cardiac implant monitoring claim must be supported by a minimum documentation set, and each element strengthens audit defense. For 93295/93296, retain the remote transmission report from the OEM portal to prove data receipt, the date and duration of the monitoring period to show frequency compliance, a physician interpretation with clinical findings to support medical necessity, and the device manufacturer, model, and serial number to confirm device-type matching.
For 93297, the hemodynamic data tracing confirms that pressure readings were reviewed, the 30-day monitoring period dates show that billing frequency rules were met, and a signed interpretation addressing clinical response demonstrates that the data informed treatment decisions. For 93298, the ICM or ILR transmission report proves that rhythm data was received, documentation that the monitoring period lasted at least 30 days supports the timing of the claim, and a physician-signed interpretation of rhythm findings links the service to clinical management.
For 93285, the procedure note must document incision site, subcutaneous pocket creation, device placement, wound closure, and that programming occurred during the same encounter. For 0650T, auditors expect synchronous physician oversight confirmation, pre- and post-reprogramming parameter documentation, and a clear clinical rationale for remote rather than in-person reprogramming.
Practices that implant devices from more than one manufacturer, including Medtronic, Boston Scientific, Abbott, Biotronik, and others, must log into separate, non-interoperable OEM portals to retrieve transmission data. Each portal uses a different interface, different alert thresholds, and different export formats. These differences create manual transcription into the EHR, inconsistent monitoring period tracking, and missed billable events when transmissions arrive outside staff hours.
Rhythm360 resolves this problem by ingesting API, HL7, XML, and PDF data from all major OEM portals into a single vendor-neutral dashboard. Computer vision and AI-powered normalization achieve greater than 99.9% data transmissibility, and a redundant feed system maintains data continuity when an OEM server is unavailable. CPT code eligibility is tracked automatically against frequency rules, including the 30-day minimum, the 90-day maximum, and the device-type matching requirements described earlier, so billing staff receive a compliant, documentation-ready claim event rather than a raw transmission file. Practices using Rhythm360 have reported up to a 300% increase in revenue capture and an 80% reduction in critical alert response times.
Schedule a demo to see how Rhythm360 removes portal fragmentation and automates compliant CPT capture across every OEM.
CPT 93297 applies to remote interrogation of an implantable cardiovascular physiologic monitor, such as a CardioMEMS pulmonary artery pressure sensor, and may be billed once per 30-day period. CPT 93298 applies to remote interrogation of an implantable cardiac monitor or implantable loop recorder, which captures rhythm data, and is associated with monitoring periods of up to 30 days. Billing the wrong code for the wrong device type remains one of the most common denial triggers in cardiac implant monitoring.
Yes, when a single practice owns both the clinical interpretation function and the data transmission infrastructure, both codes may be billed under the same NPI without a modifier split. When the technical component is owned by a hospital or independent monitoring service, 93296 is billed by that entity with modifier TC, and 93295 is billed by the interpreting physician with modifier 26. Billing both codes globally under a single NPI when the technical component belongs to a separate entity is a common audit finding.
Traditional Medicare rarely requires prior authorization for remote cardiac implant monitoring codes. However, Medicare Advantage plans may impose prior authorization requirements that differ from Traditional Medicare, and commercial payers vary widely. Practices should verify authorization requirements at the time of device implant and document the clinical indication in the medical record before the first billable transmission period begins.
For remote cardiac implant monitoring codes, including 93295, 93296, 93297, and 93298, the code descriptors reference periods up to 30 days. Claims submitted for shorter periods may face denial depending on the payer, and the denial can be difficult to appeal. Automated period tracking, rather than manual calendar review, helps prevent this error.
As of mid-2026, Medicare does not have a finalized national coverage determination for CPT 0650T, the Category III code for remote reprogramming of a cardiac implantable electronic device. Coverage is adjudicated at the Medicare Administrative Contractor level, and several MACs have not issued a formal LCD. Most commercial payers classify 0650T as investigational or non-covered. Practices should obtain written payer-specific coverage confirmation before performing remote reprogramming and retain all documentation of synchronous physician oversight to support any appeal.
The 2026 cardiac implant monitoring coding landscape demands precise device-type matching, strict adherence to 30-day and 90-day frequency rules, and audit-ready documentation for every transmission. Manual workflows across fragmented OEM portals make consistent compliance structurally difficult, and a missed 30-day minimum, a mismatched device code, or an unsigned interpretation report each creates direct revenue loss and audit exposure.
Rhythm360 addresses these challenges at the infrastructure level by ingesting data from every major manufacturer, tracking CPT eligibility automatically, and generating compliant documentation without manual transcription. This approach creates a billing workflow that captures every legitimate claim event while maintaining the documentation standard required for Medicare and commercial payer audits.
Schedule a demo to see how Rhythm360 can close revenue gaps created by multi-OEM fragmentation and automate compliant cardiac implant monitoring billing for your practice.
